Skip to main content

The latest advances in oncology research

The increased investment in cancer has brought a new era of treatments to the forefront including cell and gene therapies, antibody drug conjugates, checkpoint inhibitors and more. Looking ahead, the industry still has to overcome key hurdles in order to continue expanding access and improving outcomes.

included in this trendline
  • The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel
  • AZ oncology chief says AI can help solve cancer’s ‘ZIP code lottery’ as health disparities persist
  • With an ovarian KRAS combo ready for review, Verastem’s CEO is poised for the transition
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.